Jay C. Strum

Person

Hillsborough, NC, US

People

Patents Grantslast 30 patents

Information Patent Grant
Morphic forms of trilaciclib and methods of manufacture thereof
- Patent number 12,168,666
- Issue date Dec 17, 2024
- G1 Therapeutics, Inc.
- Stephen Schneider
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Transient protection of normal cells during chemotherapy
- Patent number 11,717,523
- Issue date Aug 8, 2023
- G1 Therapeutics, Inc.
- Jay Copeland Strum
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
HSPC-sparing treatments for RB-positive abnormal cellular prolifera...
- Patent number 11,654,148
- Issue date May 23, 2023
- G1 Therapeutics, Inc.
- Jay Copeland Strum
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted 1′,2′-dihydro-3′H-spiro[cyclohexane-1,4′-pyrimido[5′,4′...
- Patent number 11,643,416
- Issue date May 9, 2023
- G1 Therapeutics, Inc.
- Jay Copeland Strum
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Preservation of immune response during chemotherapy regimens
- Patent number 11,529,352
- Issue date Dec 20, 2022
- G1 Therapeutics, Inc.
- Jessica A. Sorrentino
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-neoplastic combinations and dosing regimens using CDK4/6 inhib...
- Patent number 11,446,295
- Issue date Sep 20, 2022
- G1 Therapeutics, Inc.
- Jay Copeland Strum
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of EGFR-driven cancer with fewer side effects
- Patent number 11,395,821
- Issue date Jul 26, 2022
- G1 Therapeutics, Inc.
- Jessica A. Sorrentino
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Combination therapy for treatment of cancer
- Patent number 11,364,222
- Issue date Jun 21, 2022
- G1 Therapeutics, Inc.
- Jay C. Strum
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
G1T38 superior dosage regimes
- Patent number 11,357,779
- Issue date Jun 14, 2022
- G1 Therapeutics, Inc.
- Andrew Beelen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of Rb-negative tumors using topoisomerase inhibitors in c...
- Patent number 11,090,306
- Issue date Aug 17, 2021
- G1 Therapeutics, Inc.
- Jay Copeland Strum
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Transient protection of normal cells during chemotherapy
- Patent number 11,040,042
- Issue date Jun 22, 2021
- G1 Therapeutics, Inc.
- Jay Copeland Strum
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Morphic forms of trilaciclib and methods of manufacture thereof
- Patent number 10,988,479
- Issue date Apr 27, 2021
- G1 Therapeutics, Inc.
- Stephen Schneider
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Benzothiophene estrogen receptor modulators
- Patent number 10,981,887
- Issue date Apr 20, 2021
- G1 Therapeutics, Inc.
- Jay Copeland Strum
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Transient protection of normal cells during chemotherapy
- Patent number 10,966,984
- Issue date Apr 6, 2021
- G1 Therapeutics, Inc.
- Jay Copeland Strum
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
HSPC-sparing treatments for RB-positive abnormal cellular prolifera...
- Patent number 10,925,878
- Issue date Feb 23, 2021
- G1 Therapeutics, Inc.
- Jay Copeland Strum
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
CDK inhibitors
- Patent number 10,927,120
- Issue date Feb 23, 2021
- GI Therapeutics, Inc.
- Francis X. Tavares
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted dihydropyrazino[1 ′,2′:1,5]pyrrolo[2,3-d]pyrimidine-bas...
- Patent number 10,829,490
- Issue date Nov 10, 2020
- GI Therapeutics, Inc.
- Jay Copeland Strum
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Highly active anti-neoplastic and anti-proliferative agents
- Patent number 10,709,711
- Issue date Jul 14, 2020
- G1 Therapeutics, Inc.
- Jay Copeland Strum
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
CDK inhibitors
- Patent number 10,696,682
- Issue date Jun 30, 2020
- G1 Therapeutics, Inc.
- Francis X. Tavares
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Transient protection of normal cells during chemotherapy
- Patent number 10,660,896
- Issue date May 26, 2020
- GI Therapeutics, Inc.
- Jay Copeland Strum
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antiproliferative pyrimidine-based compounds
- Patent number 10,654,831
- Issue date May 19, 2020
- G1 Therapeutics, Inc.
- Jay Copeland Strum
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Benzothiophene estrogen receptor modulators
- Patent number 10,633,362
- Issue date Apr 28, 2020
- G1 Therapeutics, Inc.
- Jay Copeland Strum
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pyrimidine-based compounds for the treatment of cancer
- Patent number 10,618,905
- Issue date Apr 14, 2020
- G1 Therapeutics, Inc.
- Jay Copeland Strum
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
HSPC-sparing treatments for Rb-positive abnormal cellular prolifera...
- Patent number 10,434,104
- Issue date Oct 8, 2019
- G1 Therapeutics, Inc.
- Jay Copeland Strum
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Treatment of Rb-negative tumors using topoisomerase with cyclin dep...
- Patent number 10,413,547
- Issue date Sep 17, 2019
- G1 Therapeutics, Inc.
- Jay Copeland Strum
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Tricyclic lactams for use in HSPC-sparing treatments for Rb-positiv...
- Patent number 10,376,519
- Issue date Aug 13, 2019
- G1 Therapeutics, Inc.
- Jay Copeland Strum
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-neoplastic combinations and dosing regimens using CDK4/6 inhib...
- Patent number 10,231,969
- Issue date Mar 19, 2019
- GI Therapeutics, Inc.
- Jay Copeland Strum
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Benzothiophene estrogen receptor modulators
- Patent number 10,208,011
- Issue date Feb 19, 2019
- G1 Therapeutics, Inc.
- Jay Copeland Strum
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
CDK inhibitors
- Patent number 10,189,851
- Issue date Jan 29, 2019
- G1 Therapeutics, Inc.
- Francis X. Tavares
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
CDK inhibitors
- Patent number 10,189,849
- Issue date Jan 29, 2019
- G1 Therapeutics, Inc.
- Francis X. Tavares
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
CYCLIN-DEPENDENT KINASE INHIBITING COMPOUNDS FOR THE TREATMENT OF M...
- Publication number 20240150369
- Publication date May 9, 2024
- G1 Therapeutics, Inc.
- Jay Copeland Strum
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CDK INHIBITORS
- Publication number 20240109906
- Publication date Apr 4, 2024
- G1 Therapeutics, Inc.
- Francis X. Tavares
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TRANSIENT PROTECTION OF NORMAL CELLS DURING CHEMOTHERAPY
- Publication number 20230381189
- Publication date Nov 30, 2023
- G1 Therapeutics, Inc.
- Jay Copeland Strum
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HSPC-SPARING TREATMENTS FOR RB-POSITIVE ABNORMAL CELLULAR PROLIFERA...
- Publication number 20230364098
- Publication date Nov 16, 2023
- G1 Therapeutics, Inc.
- Jay Copeland Strum
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PRESERVATION OF IMMUNE RESPONSE DURING CHEMOTHERAPY REGIMENS
- Publication number 20230302001
- Publication date Sep 28, 2023
- G1 Therapeutics, Inc.
- Jessica A. Sorrentino
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HIGHLY ACTIVE ANTI-NEOPLASTIC AND ANTI-PROLIFERATIVE AGENTS
- Publication number 20230248733
- Publication date Aug 10, 2023
- G1 Therapeutics, Inc.
- Jay Copeland Strum
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-NEOPLASTIC COMBINATIONS AND DOSING REGIMENS USING CDK4/6 INHIB...
- Publication number 20230241059
- Publication date Aug 3, 2023
- G1 Therapeutics, Inc.
- Jay Copeland Strum
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
G1T38 SUPERIOR DOSAGE REGIMES
- Publication number 20230149406
- Publication date May 18, 2023
- G1 Therapeutics, Inc.
- Andrew Beelen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Treatment of EGFR-Driven Cancer with Fewer Side Effects
- Publication number 20230146638
- Publication date May 11, 2023
- G1 Therapeutics, Inc.
- Jessica A. Sorrentino
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CYCLIN-DEPENDENT KINASE INHIBITING COMPOUNDS FOR THE TREATMENT OF M...
- Publication number 20220306644
- Publication date Sep 29, 2022
- G1 Therapeutics, Inc.
- Jay Copeland Strum
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TARGETED TREATMENT OF CANCERS WITH DYSREGULATED FIBROBLAST GROWTH F...
- Publication number 20220241275
- Publication date Aug 4, 2022
- G1 Therapeutics, Inc.
- Jay Copeland Strum
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF RB-NEGATIVE TUMORS USING TOPOISOMERASE INHIBITORS IN C...
- Publication number 20220175780
- Publication date Jun 9, 2022
- G1 Therapeutics, Inc.
- Jay Copeland Strum
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CDK INHIBITORS
- Publication number 20210395259
- Publication date Dec 23, 2021
- G1 Therapeutics, Inc.
- Francis X. Tavares
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MORPHIC FORMS OF TRILACICLIB AND METHODS OF MANUFACTURE THEREOF
- Publication number 20210387993
- Publication date Dec 16, 2021
- G1 Therapeutics, Inc.
- Stephen Schneider
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TRANSIENT PROTECTION OF NORMAL CELLS DURING CHEMOTHERAPY
- Publication number 20210299130
- Publication date Sep 30, 2021
- G1 Therapeutics, Inc.
- Jay Copeland Strum
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
THERAPEUTIC REGIMENS FOR TREATMENT OF CANCER USING ERIBULIN AND SEL...
- Publication number 20210267986
- Publication date Sep 2, 2021
- G1 Therapeutics, Inc.
- Jessica A. Sorrentino
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HSPC-SPARING TREATMENTS FOR RB-POSITIVE ABNORMAL CELLULAR PROLIFERA...
- Publication number 20210213022
- Publication date Jul 15, 2021
- G1 Therapeutics, Inc.
- Jay Copeland Strum
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BENZOTHIOPHENE ESTROGEN RECEPTOR MODULATORS TO TREAT MEDICAL DISORDERS
- Publication number 20210171554
- Publication date Jun 10, 2021
- G1 Therapeutics, Inc.
- Jay Copeland Strum
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TRANSIENT PROTECTION OF HEMATOPOIETIC STEM AND PROGENITOR CELLS AGA...
- Publication number 20210077498
- Publication date Mar 18, 2021
- G1 Therapeutics, Inc.
- Jay Copeland Strum
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PYRIMIDINE-BASED ANTIPROLIFERATIVE AGENTS
- Publication number 20210047328
- Publication date Feb 18, 2021
- G1 Therapeutics, Inc.
- Jay Copeland Strum
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TREATMENT OF CANCERS HAVING DRIVING ONCOGENIC MUTATIONS
- Publication number 20210030758
- Publication date Feb 4, 2021
- G1 Therapeutics, Inc.
- Jay Copeland Strum
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
G1T38 SUPERIOR DOSAGE REGIMES
- Publication number 20200405721
- Publication date Dec 31, 2020
- G1 Therapeutics, Inc.
- Andrew Beelen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TRANSIENT PROTECTION OF NORMAL CELLS DURING CHEMOTHERAPY
- Publication number 20200345742
- Publication date Nov 5, 2020
- G1 Therapeutics, Inc.
- Jay Copeland Strum
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HIGHLY ACTIVE ANTI-NEOPLASTIC AND ANTI-PROLIFERATIVE AGENTS
- Publication number 20200345743
- Publication date Nov 5, 2020
- G1 Therapeutics, Inc.
- Jay Copeland Strum
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF ABNORMAL CELLULAR PROLI...
- Publication number 20200331925
- Publication date Oct 22, 2020
- G1 Therapeutics, Inc.
- Jay Copeland Strum
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIPROLIFERATIVE PYRIMIDINE-BASED COMPOUNDS
- Publication number 20200283406
- Publication date Sep 10, 2020
- G1 Therapeutics, Inc.
- Jay Copeland Strum
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CDK INHIBITORS
- Publication number 20200277300
- Publication date Sep 3, 2020
- G1 Therapeutics, Inc.
- Francis X. Tavares
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PYRIMIDINE-BASED COMPOUNDS FOR THE TREATMENT OF CANCER
- Publication number 20200239486
- Publication date Jul 30, 2020
- G1 Therapeutics, Inc.
- Jay Copeland Strum
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BENZOTHIOPHENE ESTROGEN RECEPTOR MODULATORS
- Publication number 20200216406
- Publication date Jul 9, 2020
- G1 Therapeutics, Inc.
- Jay Copeland Strum
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TREATMENT OF RB-NEGATIVE TUMORS USING TOPOISOMERASE INHIBITORS IN C...
- Publication number 20200022983
- Publication date Jan 23, 2020
- G1 Therapeutics, Inc.
- Jay Copeland Strum
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Jay C. Strum

Person

Patents Grantslast 30 patents

Morphic forms of trilaciclib and methods of manufacture thereof

Transient protection of normal cells during chemotherapy

HSPC-sparing treatments for RB-positive abnormal cellular prolifera...

Substituted 1′,2′-dihydro-3′H-spiro[cyclohexane-1,4′-pyrimido[5′,4′...

Preservation of immune response during chemotherapy regimens

Anti-neoplastic combinations and dosing regimens using CDK4/6 inhib...

Treatment of EGFR-driven cancer with fewer side effects

Combination therapy for treatment of cancer

G1T38 superior dosage regimes

Treatment of Rb-negative tumors using topoisomerase inhibitors in c...

Transient protection of normal cells during chemotherapy

Morphic forms of trilaciclib and methods of manufacture thereof

Benzothiophene estrogen receptor modulators

Transient protection of normal cells during chemotherapy

HSPC-sparing treatments for RB-positive abnormal cellular prolifera...

CDK inhibitors

Substituted dihydropyrazino[1 ′,2′:1,5]pyrrolo[2,3-d]pyrimidine-bas...

Highly active anti-neoplastic and anti-proliferative agents

CDK inhibitors

Transient protection of normal cells during chemotherapy

Antiproliferative pyrimidine-based compounds

Benzothiophene estrogen receptor modulators

Pyrimidine-based compounds for the treatment of cancer

HSPC-sparing treatments for Rb-positive abnormal cellular prolifera...

Treatment of Rb-negative tumors using topoisomerase with cyclin dep...

Tricyclic lactams for use in HSPC-sparing treatments for Rb-positiv...

Anti-neoplastic combinations and dosing regimens using CDK4/6 inhib...

Benzothiophene estrogen receptor modulators

CDK inhibitors

CDK inhibitors

Patents Applicationslast 30 patents

CYCLIN-DEPENDENT KINASE INHIBITING COMPOUNDS FOR THE TREATMENT OF M...

CDK INHIBITORS

TRANSIENT PROTECTION OF NORMAL CELLS DURING CHEMOTHERAPY

HSPC-SPARING TREATMENTS FOR RB-POSITIVE ABNORMAL CELLULAR PROLIFERA...

PRESERVATION OF IMMUNE RESPONSE DURING CHEMOTHERAPY REGIMENS

HIGHLY ACTIVE ANTI-NEOPLASTIC AND ANTI-PROLIFERATIVE AGENTS

ANTI-NEOPLASTIC COMBINATIONS AND DOSING REGIMENS USING CDK4/6 INHIB...

G1T38 SUPERIOR DOSAGE REGIMES

Treatment of EGFR-Driven Cancer with Fewer Side Effects

CYCLIN-DEPENDENT KINASE INHIBITING COMPOUNDS FOR THE TREATMENT OF M...

TARGETED TREATMENT OF CANCERS WITH DYSREGULATED FIBROBLAST GROWTH F...

TREATMENT OF RB-NEGATIVE TUMORS USING TOPOISOMERASE INHIBITORS IN C...

CDK INHIBITORS

MORPHIC FORMS OF TRILACICLIB AND METHODS OF MANUFACTURE THEREOF

TRANSIENT PROTECTION OF NORMAL CELLS DURING CHEMOTHERAPY

THERAPEUTIC REGIMENS FOR TREATMENT OF CANCER USING ERIBULIN AND SEL...

HSPC-SPARING TREATMENTS FOR RB-POSITIVE ABNORMAL CELLULAR PROLIFERA...

BENZOTHIOPHENE ESTROGEN RECEPTOR MODULATORS TO TREAT MEDICAL DISORDERS

TRANSIENT PROTECTION OF HEMATOPOIETIC STEM AND PROGENITOR CELLS AGA...

PYRIMIDINE-BASED ANTIPROLIFERATIVE AGENTS

TREATMENT OF CANCERS HAVING DRIVING ONCOGENIC MUTATIONS

G1T38 SUPERIOR DOSAGE REGIMES

TRANSIENT PROTECTION OF NORMAL CELLS DURING CHEMOTHERAPY

HIGHLY ACTIVE ANTI-NEOPLASTIC AND ANTI-PROLIFERATIVE AGENTS

HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF ABNORMAL CELLULAR PROLI...

ANTIPROLIFERATIVE PYRIMIDINE-BASED COMPOUNDS

CDK INHIBITORS

PYRIMIDINE-BASED COMPOUNDS FOR THE TREATMENT OF CANCER

BENZOTHIOPHENE ESTROGEN RECEPTOR MODULATORS

TREATMENT OF RB-NEGATIVE TUMORS USING TOPOISOMERASE INHIBITORS IN C...